Suppression of serum vascular endothelial growth factor immunoreactivity in normal pregnancy and in pre‐eclampsia
- 1 February 1997
- journal article
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 104 (2), 223-228
- https://doi.org/10.1111/j.1471-0528.1997.tb11050.x
Abstract
Objective To determine whether vascular endothelial growth factor (VEGF) concentrations are altered in pre-eclampsia. Design Serum was prepared from peripheral venous blood and stored at −70°C. Serum VEGF concentrations were measured by ELISA. Setting University of Glasgow Department of Obstetrics and Gynaecology, Royal Infirmary, Glasgow. Participants Twenty-two healthy nonpregnant volunteer women, 34 normal pregnant women and 34 women with pre-eclampsia were studied. Results Serum concentrations of VEGF were significantly lower in normal pregnant women (median value 12.89 pg/mL) than in nonpregnant women (median value 166 pg/mL; P < 0.0001). In pre-eclampsia VEGF concentrations were significantly lower (median value 2.34 pg/mL) than normal pregnancies (P < 0.0001). Postpartum concentrations of VEGF in the group complicated by pre-eclampsia (median value 76.42 pg/mL) were not significantly different from nonpregnant values (P= 0.2). Conclusions Our results show that serum concentrations of VEGF are suppressed in pregnancy and further reduced in pre-eclampsia. Further studies to elucidate the mechanisms which lead to a reduction in VEGF concentrations may provide new clues to the aetiology of this disorder.Keywords
This publication has 49 references indexed in Scilit:
- AUTHORS' REPLYBJOG: An International Journal of Obstetrics and Gynaecology, 1995
- Pre-eclampsiaJournal Of Hypertension, 1994
- The use of Butcher series in the analysis of Newton-like iterations in Runge–Kutta formulasApplied Numerical Mathematics, 1994
- Modalities for reducing interleukin 1 activity in diseaseImmunology Today, 1993
- Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factorBiochemical and Biophysical Research Communications, 1992
- The fms -Like Tyrosine Kinase, a Receptor for Vascular Endothelial Growth FactorScience, 1992
- Molecular and biological properties of the vascular endothelial growth factor family of proteinsEndocrine Reviews, 1992
- Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitroImmunology Today, 1991
- Interaction of vasculotropin/vascular endothelial cell growth factor with human umbilical vein endothelial cells: Binding, internalization, degradation, and biological effectsJournal of Cellular Physiology, 1991
- Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cellsBiochemical and Biophysical Research Communications, 1989